UK markets close in 5 hours 4 minutes

BIOLASE, Inc. (BIOL)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1484+0.0038 (+2.63%)
At close: 04:00PM EDT
0.1509 +0.00 (+1.68%)
Pre-market: 04:52AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.94M
Enterprise value 16.28M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.00
Price/book (mrq)0.77
Enterprise value/revenue 0.33
Enterprise value/EBITDA -1.05

Trading information

Stock price history

Beta (5Y monthly) 0.69
52-week change 3-99.30%
S&P500 52-week change 321.33%
52-week high 332.0000
52-week low 30.1300
50-day moving average 30.1514
200-day moving average 31.8523

Share statistics

Avg vol (3-month) 35.89M
Avg vol (10-day) 3772.1k
Shares outstanding 533.26M
Implied shares outstanding 633.26M
Float 832.4M
% held by insiders 10.33%
% held by institutions 18.01%
Shares short (15 Apr 2024) 4592.68k
Short ratio (15 Apr 2024) 40.06
Short % of float (15 Apr 2024) 41.78%
Short % of shares outstanding (15 Apr 2024) 41.78%
Shares short (prior month 15 Mar 2024) 4288.87k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 311 May 2018
Ex-dividend date 424 Jun 2005
Last split factor 21:100
Last split date 328 Jul 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -41.97%
Operating margin (ttm)-34.66%

Management effectiveness

Return on assets (ttm)-28.55%
Return on equity (ttm)-602.83%

Income statement

Revenue (ttm)49.16M
Revenue per share (ttm)38.47
Quarterly revenue growth (yoy)-4.00%
Gross profit (ttm)N/A
EBITDA -13.94M
Net income avi to common (ttm)-37.62M
Diluted EPS (ttm)-29.4400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.57M
Total cash per share (mrq)0.2
Total debt (mrq)15.71M
Total debt/equity (mrq)803.02%
Current ratio (mrq)1.26
Book value per share (mrq)-0.07

Cash flow statement

Operating cash flow (ttm)-14.09M
Levered free cash flow (ttm)-2.27M